ArticleMolecular biotechnology2024

Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.

Jie Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.